XML 347 R54.htm IDEA: XBRL DOCUMENT v3.26.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2025
Financial Instruments [Abstract]  
Schedule of Fair Value Measurement Methods The approaches, in order of strongest fair value evidence, are detailed as follows:
Valuation Method
Description
Market – Backsolve
The market backsolve approach benchmarks the original issue price (OIP) of the company’s latest
funding transaction as current value.
Market/Asset – PWERM
Under a PWERM, the company value is based upon the probability-weighted present value of
expected future investment returns, considering each of the possible future outcomes available to
the enterprise. Possible future outcomes can include IPO scenarios, potential SPAC transactions,
merger and acquisition transactions as well as other similar exit transactions of the investee.
Income Based – DCF
The income approach is used to estimate fair value based on the income streams, such as cash flows
or earnings, that an asset or business can be expected to generate.
The methods are detailed as follows:
Allocation Method
Description
OPM
The OPM model treats preferred stock as call options on the enterprise’s equity value, with exercise
prices based on the liquidation preferences of the preferred stock.
PWERM
Under a PWERM, share value is based upon the probability-weighted present value of expected
future investment returns, considering each of the possible future outcomes available to the
enterprise, as well as the rights of each share class.
Hybrid
The hybrid method is a combination of the PWERM and OPM. Under the hybrid method, multiple
liquidity scenarios are weighted based on the probability of the scenario's occurrence, similar to the
PWERM, while also utilizing the OPM to estimate the allocation of value in one or more of the
scenarios.
The Group measures fair value using the following fair value hierarchy that reflects the significance of the
inputs used in making the measurements:
Fair Value
Hierarchy Level
Description
Level 1
Inputs that are quoted market prices (unadjusted) in active markets for identical instruments.
Level 2
Inputs other than quoted prices included within Level 1 that are observable either directly (i.e. as
prices) or indirectly (i.e. derived from prices).
Level 3
Inputs that are unobservable. This category includes all instruments for which the valuation technique
includes inputs not based on observable data and the unobservable inputs have a significant effect
on the instruments' valuation.
Schedule of Changes in Assets, Level 3 Fair Value, Investments Held at Fair Value The following table summarizes the changes in all the Group’s investments held at fair value categorized as Level 3 in the fair
value hierarchy:
Level 3 Investments held at fair value
Balance under
IFRS 9
$
Equity method
loss recorded
against LTI
$
Carrying Amount
$
Balance as of January 1, 2024
24,872
24,872
Deconsolidation of Seaport - new investment in Seaport preferred shares
179,248
179,248
Gain/(loss) on changes in fair value
(10,361)
(10,361)
Equity method loss recorded against LTI
(5,307)
(5,307)
Balance as of December 31, 2024
193,758
(5,307)
188,452
Investment in Vedanta preferred shares
888
888
Conversion of Vedanta note to preferred shares
2,836
2,836
Gain/(loss) on changes in fair value
39,074
39,074
Equity method loss recorded against LTI, net
(13,831)
(13,831)
Balance as of December 31, 2025
236,557
(19,138)
217,419
Schedule of Sensitivity Analysis of Fair Value Measurement to Changes in Unobservable Inputs, Liabilities The significant unobservable inputs used at December 31, 2025
in the fair value measurement of this investment and the sensitivity of the fair value measurement to changes in these significant
unobservable inputs are summarized in the table below.
As of December 31, 2025
Investment Measured through
Market Backsolve & PWERM
Unobservable Inputs
Input Value
Sensitivity Range
Fair Value Increase/
(Decrease) $
Equity Value
689,748
-10%
(24,667)
+10%
24,634
Probability of entering into an initial public offering ("IPO")*
50%
-10%
(5,270)
+10%
5,270
*Assumed the IPO event occurs on June 30, 2026.
Schedule of Fair Value Measurement and Classification The fair value of financial instruments by category as of December 31, 2025 and 2024:
2025
Carrying Amount
Fair Value
Financial Assets
$
Financial
Liabilities
$
Level 1
$
Level 2
$
Level 3
$
Total
$
Financial assets1:
Money Markets2
97,447
97,447
97,447
Investment in notes from associates
11,417
11,417
11,417
Investments held at fair value3
217,426
7
217,419
217,426
Total financial assets
326,290
97,454
228,836
326,290
Financial liabilities:
Subsidiary preferred shares
169
169
169
Share-based liability awards
3,044
3,044
3,044
Total financial liabilities
3,213
3,213
3,213
1.Excluded from the table above are short-term investments of $24,829 and cash equivalent of $124,538 that are classified at amortized cost as of December 31, 2025. The cost of these
short-term investments and cash equivalent approximates current fair value.
2.Included within cash and cash equivalents.
3.The carrying amount of  $217,419 reflects the fair value of $236,557 as of December 31, 2025, net of $19,138 in equity method loss allocated to the long-term interest.
2024
Carrying Amount
Fair Value
Financial Assets
$
Financial
Liabilities
$
Level 1
$
Level 2
$
Level 3
$
Total
$
Financial assets1:
Money Markets2
181,716
181,716
181,716
Investment in notes from associates
17,731
17,731
17,731
Investments held at fair value3
191,426
2,974
188,452
191,426
Total financial assets
390,873
184,690
206,183
390,873
Financial liabilities:
Subsidiary preferred shares
169
169
169
Share-based liability awards
3,736
3,736
3,736
Total financial liabilities
3,905
3,905
3,905
1.Excluded from the table above are short-term investments of $86,666 and cash equivalent of $62,179 that are classified at amortized cost as of December 31, 2024. The cost of these
short-term investments and cash equivalent approximates current fair value.
2.Included within cash and cash equivalents.
3.The carrying amount of $188,452 reflects the fair value of $193,758 as of December 31, 2024, net of $5,307 in equity method loss allocated to the long-term interest.